EMCURE PHARMACEUTICALS
Back to Balance Sheet
|
EMCURE PHARMACEUTICALS Last 5 Year Trade Payables History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Trade Payables | ₹1,480 Cr | ₹1,309 Cr | ₹1,086 Cr | ₹1,125 Cr | ₹972 Cr |
What is the latest Trade Payables ratio of EMCURE PHARMACEUTICALS ?
| Year | Trade Payables |
|---|---|
| Mar2025 | ₹1,480 Cr |
| Mar2024 | ₹1,309 Cr |
| Mar2023 | ₹1,086 Cr |
| Mar2022 | ₹1,125 Cr |
| Mar2021 | ₹972 Cr |
How is Trade Payables of EMCURE PHARMACEUTICALS Trending?
| Years | Trade Payables | % Change | |
|---|---|---|---|
| Mar2025 | ₹1,480 Cr | 13.00 | |
| Mar2024 | ₹1,309 Cr | 20.56 | |
| Mar2023 | ₹1,086 Cr | -3.47 | |
| Mar2022 | ₹1,125 Cr | 15.74 | |
| Mar2021 | ₹972 Cr | - | |
Compare Trade Payables of peers of EMCURE PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| EMCURE PHARMACEUTICALS | ₹35,871.3 Cr | 4.9% | 5.5% | 41.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹466,179.0 Cr | -0.4% | 4.3% | 13.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹196,095.0 Cr | 0.9% | 8.9% | 8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹191,530.0 Cr | 0.7% | 13% | 46.5% | Stock Analytics | |
| CIPLA | ₹114,318.0 Cr | -1% | -0% | -3.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹98,742.1 Cr | -3.3% | -8.4% | -4.3% | Stock Analytics | |
EMCURE PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| EMCURE PHARMACEUTICALS | 4.9% |
5.5% |
41.3% |
| SENSEX | -0.6% |
-0.1% |
-6.7% |
You may also like the below Video Courses